/
/
/

Solara Active Pharma Sciences Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018
₹382 Cr₹387 Cr₹349 Cr₹314 Cr₹319 Cr₹273 Cr₹300 Cr₹347 Cr₹363 Cr₹299 Cr₹212 Cr₹425 Cr₹352 Cr₹381 Cr₹395 Cr₹338 Cr₹330 Cr₹361 Cr₹100 Cr₹402 Cr₹406 Cr₹444 Cr₹427 Cr₹398 Cr₹348 Cr₹297 Cr₹344 Cr₹351 Cr₹330 Cr₹385 Cr₹356 Cr₹342 Cr₹303 Cr
₹3 Cr₹5 Cr₹0₹49 L₹98 L₹6 Cr₹1 Cr₹32 L₹56 L₹2 Cr₹45 L₹1 Cr₹2 Cr₹5 Cr₹7 Cr₹4 Cr₹7 Cr₹6 Cr₹5 Cr₹3 Cr₹6 Cr₹10 Cr₹8 Cr₹6 Cr₹5 Cr₹12 Cr₹6 Cr₹5 Cr₹4 Cr₹7 Cr₹4 Cr₹1 Cr₹48 L
₹384 Cr₹392 Cr₹349 Cr₹314 Cr₹320 Cr₹279 Cr₹302 Cr₹347 Cr₹364 Cr₹301 Cr₹212 Cr₹426 Cr₹354 Cr₹385 Cr₹402 Cr₹342 Cr₹337 Cr₹367 Cr₹105 Cr₹405 Cr₹411 Cr₹454 Cr₹435 Cr₹404 Cr₹353 Cr₹309 Cr₹350 Cr₹356 Cr₹335 Cr₹392 Cr₹360 Cr₹344 Cr₹303 Cr
₹346 Cr₹356 Cr₹337 Cr₹303 Cr₹286 Cr₹252 Cr₹267 Cr₹311 Cr₹347 Cr₹315 Cr₹400 Cr₹414 Cr₹359 Cr₹358 Cr₹378 Cr₹339 Cr₹346 Cr₹375 Cr₹226 Cr₹358 Cr₹342 Cr₹373 Cr₹349 Cr₹328 Cr₹291 Cr₹271 Cr₹290 Cr₹307 Cr₹289 Cr₹344 Cr₹315 Cr₹314 Cr₹276 Cr
₹65 Cr₹62 Cr₹37 Cr₹35 Cr₹58 Cr₹51 Cr₹59 Cr₹62 Cr₹42 Cr₹11 Cr-₹161 Cr₹39 Cr₹21 Cr₹53 Cr₹52 Cr₹31 Cr₹20 Cr₹20 Cr-₹92 Cr₹75 Cr₹97 Cr₹109 Cr₹114 Cr₹104 Cr₹88 Cr₹62 Cr₹84 Cr₹73 Cr₹68 Cr₹71 Cr₹66 Cr₹49 Cr₹47 Cr
₹22 Cr₹28 Cr₹22 Cr₹21 Cr₹24 Cr₹29 Cr₹27 Cr₹28 Cr₹31 Cr₹31 Cr₹25 Cr₹24 Cr₹25 Cr₹22 Cr₹24 Cr₹22 Cr₹23 Cr₹21 Cr₹18 Cr₹17 Cr₹19 Cr₹25 Cr₹20 Cr₹19 Cr₹20 Cr₹20 Cr₹19 Cr₹20 Cr₹19 Cr₹22 Cr₹23 Cr₹20 Cr₹18 Cr
₹16 Cr₹10 Cr-₹17 Cr-₹10 Cr₹11 Cr-₹2 Cr₹8 Cr₹8 Cr-₹13 Cr-₹167 Cr-₹275 Cr-₹17 Cr-₹29 Cr₹5 Cr₹55 L-₹19 Cr-₹31 Cr-₹31 Cr-₹140 Cr₹30 Cr₹50 Cr₹57 Cr₹66 Cr₹57 Cr₹42 Cr₹18 Cr₹41 Cr₹29 Cr₹27 Cr₹26 Cr₹22 Cr₹10 Cr₹9 Cr
₹16 Cr₹10 Cr-₹17 Cr-₹10 Cr₹11 Cr-₹2 Cr₹8 Cr₹8 Cr-₹13 Cr-₹255 Cr-₹275 Cr-₹17 Cr-₹19 Cr₹4 Cr₹43 L-₹10 Cr-₹16 Cr₹2 Cr-₹140 Cr₹30 Cr₹50 Cr₹57 Cr₹66 Cr₹57 Cr₹42 Cr₹18 Cr₹41 Cr₹29 Cr₹27 Cr₹26 Cr₹22 Cr₹9 Cr₹3 Cr

Share Price Live Stats

Open (₹)628.00
Volume (₹)62,356.00
High (₹)629.10
Upper Circuit755.80
Low (₹)619.00
Lower Circuit503.90
Prev Close629.85
52W High (₹)712.00
Price623.10
52W Low (₹)422.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)3040.02 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity0.53
Price to Book1.52
Book Value280.27
EPS (TTM)-0.34
Face Value10.00
ROE (%)-0.63

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
SOLARANSE
LTP
1W Low
1W High
Market cap (₹)
1906.6-13.4 (-0.70%)
1905
1984.80
4,56,833Cr
9185.5-53.5 (-0.58%)
9087
9467
2,45,426Cr
4910-140 (-2.77%)
4886.50
5066
1,87,320Cr
1135.4-55.6 (-4.67%)
1125.10
1187
1,13,217Cr
1386.6-36.9 (-2.59%)
1376.70
1426.10
1,12,212Cr
1858.7-79.8 (-4.12%)
1811.70
1949
1,01,155Cr
2125.3-46.2 (-2.13%)
2118.10
2192
97,626Cr
2357.4-25.5 (-1.07%)
2341.20
2419.20
96,859Cr
1162.8-15.2 (-1.29%)
1154.40
1179.90
96,406Cr
1647.5+2.2 (0.13%)
1622.60
1717
93,614Cr
623.1-0.6 (-0.10%)
615.35
674
3,040Cr

Key Highlights of Solara Active Pharma Sciences Ltd’s P&L

In 2026-03-31, Solara Active Pharma Sciences Ltd reported total revenue of ₹1375.14Cr, compared with ₹1292.08Cr in 2025-03-31, reflecting Solara Active Pharma Sciences Ltd turnover.

Depreciation was ₹99.68Cr and finance costs were ₹94.75Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹-₹7.41Cr in 2026-03-31 as compared to ₹54Lakh in 2025-03-31.

Net Profit (PAT) was ₹-₹7.41Cr in 2026-03-31 compared with ₹54Lakh in 2025-03-31.

Earnings per share (EPS) were ₹-1.66 in 2026-03-31, compared with ₹0.13 in 2025-03-31.